AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in AN2 Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −8 vs. Q1 2024
- Shares held
- 19.4M
- +709.0K (+3.8%) vs. Q1 2024
- Total value
- $41.7M
- −$19.1M (−31.4%) vs. Q1 2024
- New holders
- 6
- 14 more added
- Sold out
- 14
- 13 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 5,551,295 | $11.9M | 0.16% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 3,220,263 | $6.92M | 1.14% | +2,117,263+192.0% | Added |
| Frazier Life Sciences Management, L.P. | 2,088,889 | $4.49M | 0.21% | +700,000+50.4% | Added |
| TCG Crossover Management, LLC | 1,555,118 | $3.34M | 0.35% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,553,829 | $3.34M | 0.00% | −2,725−0.2% | Reduced |
| Janus Henderson Group PLC | 1,221,051 | $2.61M | 0.00% | −940.0% | Reduced |
| Vanguard Group Inc | 1,041,527 | $2.24M | 0.00% | −6,242−0.6% | Reduced |
| Millennium Management LLC | 526,352 | $1.13M | 0.00% | +429,438+443.1% | Added |
| Adage Capital Partners GP, L.L.C. | 312,615 | $672.1K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 299,703 | $644.4K | 0.00% | +8,617+3.0% | Added |
| Goldman Sachs Group Inc | 224,185 | $482.0K | 0.00% | +195,815+690.2% | Added |
| Ghost Tree Capital, LLC | 219,331 | $471.6K | 0.16% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 180,923 | $389.1K | 0.00% | +1,553+0.9% | Added |
| Two Sigma Advisers, LP | 134,700 | $289.6K | 0.00% | +134,700 | New |
| Two Sigma Investments, LP | 132,088 | $284.0K | 0.00% | +37,920+40.3% | Added |
| Bridgeway Capital Management, LLC | 104,292 | $224.2K | 0.01% | +78,000+296.7% | Added |
| Alyeska Investment Group, L.P. | 100,000 | $215.0K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 98,278 | $211.3K | 0.02% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 97,063 | $208.7K | 0.00% | +47,456+95.7% | Added |
| Marshall Wace, LLP | 96,111 | $206.6K | 0.00% | +13,613+16.5% | Added |
| Walleye Capital LLC | 92,406 | $198.7K | 0.00% | −40,381−30.4% | Reduced |
| Acadian Asset Management LLC | 86,948 | $185.0K | 0.00% | −76,548−46.8% | Reduced |
| State Street Corp | 60,302 | $129.6K | 0.00% | 00.0% | Unchanged |
| RMB Capital Management, LLC | 45,942 | $98.8K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 38,918 | $83.7K | 0.01% | −1,382−3.4% | Reduced |
| Citigroup Inc | 37,887 | $81.5K | 0.00% | −32,920−46.5% | Reduced |
| Occudo Quantitative Strategies LP | 35,366 | $76.0K | 0.01% | −2,331−6.2% | Reduced |
| Northern Trust Corp | 32,595 | $70.1K | 0.00% | −3,768−10.4% | Reduced |
| Susquehanna International Group, LLP | 31,245 | $67.2K | 0.00% | −171,605−84.6% | Reduced |
| Captrust Financial Advisors | 28,667 | $61.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 25,150 | $54.1K | 0.00% | −12,965−34.0% | Reduced |
| Private Advisor Group, LLC | 22,500 | $48.4K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 21,774 | $46.8K | 0.00% | +21,774 | New |
| UBS Group AG | 17,483 | $37.6K | 0.00% | −2,091−10.7% | Reduced |
| Morgan Stanley | 17,461 | $37.5K | 0.00% | +13,297+319.3% | Added |
| Bank of America Corp | 15,636 | $33.6K | 0.00% | +664+4.4% | Added |
| Renaissance Technologies LLC | 14,300 | $30.7K | 0.00% | +14,300 | New |
| Cubist Systematic Strategies, LLC | 12,825 | $27.6K | 0.00% | +12,825 | New |
| Qube Research & Technologies Ltd | 10,186 | $21.9K | 0.00% | −40,179−79.8% | Reduced |
| Tower Research Capital LLC (TRC) | 5,406 | $11.6K | 0.00% | +4,293+385.7% | Added |
| Royal Bank of Canada | 2,812 | $6.00K | 0.00% | +2,812 | New |
| JPMorgan Chase & Co | 1,020 | $2.19K | 0.00% | +1,020 | New |
| Federated Hermes, Inc. | 917 | $1.97K | 0.00% | +706+334.6% | Added |
| Advisor Group Holdings, Inc. | 300 | $645 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 250 | $537 | 0.00% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −1,239,470−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,150,000−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −76,200−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −59,166−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −43,814−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −38,666−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −28,318−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,366−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −20,575−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −22,001−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −11,905−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −9,251−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −128−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |